Hypertrophic cardiomyopathy: Can the horse be put back in the barn?

Journal of the American College of Cardiology

Volumn 65, Issue 6, 2015, Pages 570-572

  Wheeler, Matthew T ^a   Ashley, Euan A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiac development; hypertrophic cardiomyopathy; mouse models

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; DOXYCYCLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; MYOSIN HEAVY CHAIN; RNA;

ABLATION THERAPY; CARDIOVERSION; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG TREATMENT FAILURE; EXERCISE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENETIC VARIABILITY; HEART SEPTAL REDUCTION; HEART SURGERY; HERITABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; NOTE; PALLIATIVE THERAPY; PATHOGENESIS; SARCOMERE GENE; TRANSGENE; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME; ANIMAL; GENETICS; MALE; MUTATION; SARCOMERE;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; MALE; MUTATION; MYOSIN HEAVY CHAINS; RNA; SARCOMERES;

EID: 84922949445     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.12.004     Document Type: Editorial

References (18)

1. S.R. Ommen Hypertrophic cardiomyopathy Curr Probl Cardiol 36 2011 409 453
2. A.A. Geisterfer-Lowrance, S. Kass, and G. Tanigawa A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation Cell 62 1990 999 1006
3. A.A. Geisterfer-Lowrance, M. Christe, and D.A. Conner A mouse model of familial hypertrophic cardiomyopathy Science 272 1996 731 734
4. H. Watkins, H. Ashrafian, and W.J. Mckenna The genetics of hypertrophic cardiomyopathy: Teare redux Heart 94 2008 1264 1268
5. M. Wheeler, A. Pavlovic, E. DeGoma, H. Salisbury, C. Brown, and E.A. Ashley A new era in clinical genetic testing for hypertrophic cardiomyopathy J Cardiovasc Transl Res 2 2009 381 391
6. P.M. Elliott, A. Anastasakis, and M.A. Borger 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2014 2733 2779
7. B.J. Gersh, B.J. Maron, and R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e212 e260
8. B.J. Maron, J.A. Dearani, and S.R. Ommen The case for surgery in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2044 2053
9. Wheeler M, Sinha N, Finsterbach TP, Ashley EA. Allele specific silencing of a hypertrophic cardiomyopathy mutation. Poster presented at: Keystone Symposia on Molecular and Cellular Biology (A7), January 17, 2010, Keystone, CO.
10. K. Zaleta, M. Wheeler, T.P. Finsterbach, and E.A. Ashley Allele specific silencing of mutant alleles in hypertrophic cardiomyopathy J RNAi Gene Silencing 9 2013 486 489
11. J. Jiang, H. Wakimoto, J.G. Seidman, and C.E. Seidman Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy Science 342 2013 111 114
12. R. Coppini, C. Ferrantini, and L. Yao Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy Circulation 127 2013 575 584
13. J.A. Spudich One path to understanding energy transduction in biological systems Nat Med 18 2012 1478 1482
14. L. Cannon, Z.-Y. Yu, and T. Marciniec Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period J Am Coll Cardiol 65 2015 560 569
15. R. Patel, S.F. Nagueh, and N. Tsybouleva Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation 104 2001 317 324
16. V. Senthil, S.N. Chen, and N. Tsybouleva Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy Circ Res 97 2005 285 292
17. R. Lombardi, G. Rodriguez, and S.N. Chen Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms Circulation 119 2009 1398 1407
18. S. Lutucuta, N. Tsybouleva, and M. Ishiyama Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice J Am Coll Cardiol 44 2004 2221 2230